AAG
HELP

Armstrong Advisory Group’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Armstrong Advisory Group’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.89K Buy
+153
New +$1.6K ﹤0.01% 941

Other funds holding HELP

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
WIM
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
KTC
Kentucky Trust Company Danville, Kentucky $200M AUM 22.53% 1-Year Est. Return
NL
NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Armstrong Advisory Group's HELP Position: Q3 2026 in Review

Armstrong Advisory Group opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q3 2026: 153 shares worth $1.89K. The stake represents ﹤0.01% of the portfolio and ranks #941 among its holdings.

8 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • Armstrong Advisory Group held 153 shares of Helus Pharma Inc. Common Stock worth $1.89K as of Q3 2026.
  • Helus Pharma Inc. Common Stock was a new Armstrong Advisory Group position in Q3 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #941 holding.
  • 8 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.